Global Nicotinamide Mononucleotide Supplement Market Growth 2022-2028

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Years Considered
• 1.3 Research Objectives
• 1.4 Market Research Methodology
• 1.5 Research Process and Data Source
• 1.6 Economic Indicators
• 1.7 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Nicotinamide Mononucleotide Supplement Annual Sales 2017-2028
  • 2.1.2 World Current & Future Analysis for Nicotinamide Mononucleotide Supplement by Geographic Region, 2017, 2022 & 2028
  • 2.1.3 World Current & Future Analysis for Nicotinamide Mononucleotide Supplement by Country/Region, 2017, 2022 & 2028
• 2.2 Nicotinamide Mononucleotide Supplement Segment by Type
  • 2.2.1 Powder
  • 2.2.2 Tablets
  • 2.2.3 Solution
  • 2.2.4 Capsules
• 2.3 Nicotinamide Mononucleotide Supplement Sales by Type
  • 2.3.1 Global Nicotinamide Mononucleotide Supplement Sales Market Share by Type (2017-2022)
  • 2.3.2 Global Nicotinamide Mononucleotide Supplement Revenue and Market Share by Type (2017-2022)
  • 2.3.3 Global Nicotinamide Mononucleotide Supplement Sale Price by Type (2017-2022)
• 2.4 Nicotinamide Mononucleotide Supplement Segment by Sales Channel
  • 2.4.1 Online Sales
  • 2.4.2 Pharmacy Sales
  • 2.4.3 Supermarket Sales
• 2.5 Nicotinamide Mononucleotide Supplement Sales by Sales Channel
  • 2.5.1 Global Nicotinamide Mononucleotide Supplement Sale Market Share by Sales Channel (2017-2022)
  • 2.5.2 Global Nicotinamide Mononucleotide Supplement Revenue and Market Share by Sales Channel (2017-2022)
  • 2.5.3 Global Nicotinamide Mononucleotide Supplement Sale Price by Sales Channel (2017-2022)

3 Global Nicotinamide Mononucleotide Supplement by Company

• 3.1 Global Nicotinamide Mononucleotide Supplement Breakdown Data by Company
  • 3.1.1 Global Nicotinamide Mononucleotide Supplement Annual Sales by Company (2020-2022)
  • 3.1.2 Global Nicotinamide Mononucleotide Supplement Sales Market Share by Company (2020-2022)
• 3.2 Global Nicotinamide Mononucleotide Supplement Annual Revenue by Company (2020-2022)
  • 3.2.1 Global Nicotinamide Mononucleotide Supplement Revenue by Company (2020-2022)
  • 3.2.2 Global Nicotinamide Mononucleotide Supplement Revenue Market Share by Company (2020-2022)
• 3.3 Global Nicotinamide Mononucleotide Supplement Sale Price by Company
• 3.4 Key Manufacturers Nicotinamide Mononucleotide Supplement Producing Area Distribution, Sales Area, Product Type
  • 3.4.1 Key Manufacturers Nicotinamide Mononucleotide Supplement Product Location Distribution
  • 3.4.2 Players Nicotinamide Mononucleotide Supplement Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Nicotinamide Mononucleotide Supplement by Geographic Region

• 4.1 World Historic Nicotinamide Mononucleotide Supplement Market Size by Geographic Region (2017-2022)
  • 4.1.1 Global Nicotinamide Mononucleotide Supplement Annual Sales by Geographic Region (2017-2022)
  • 4.1.2 Global Nicotinamide Mononucleotide Supplement Annual Revenue by Geographic Region
• 4.2 World Historic Nicotinamide Mononucleotide Supplement Market Size by Country/Region (2017-2022)
  • 4.2.1 Global Nicotinamide Mononucleotide Supplement Annual Sales by Country/Region (2017-2022)
  • 4.2.2 Global Nicotinamide Mononucleotide Supplement Annual Revenue by Country/Region
• 4.3 Americas Nicotinamide Mononucleotide Supplement Sales Growth
• 4.4 APAC Nicotinamide Mononucleotide Supplement Sales Growth
• 4.5 Europe Nicotinamide Mononucleotide Supplement Sales Growth
• 4.6 Middle East & Africa Nicotinamide Mononucleotide Supplement Sales Growth

5 Americas

• 5.1 Americas Nicotinamide Mononucleotide Supplement Sales by Country
  • 5.1.1 Americas Nicotinamide Mononucleotide Supplement Sales by Country (2017-2022)
  • 5.1.2 Americas Nicotinamide Mononucleotide Supplement Revenue by Country (2017-2022)
• 5.2 Americas Nicotinamide Mononucleotide Supplement Sales by Type
• 5.3 Americas Nicotinamide Mononucleotide Supplement Sales by Sales Channel
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Brazil

6 APAC

• 6.1 APAC Nicotinamide Mononucleotide Supplement Sales by Region
  • 6.1.1 APAC Nicotinamide Mononucleotide Supplement Sales by Region (2017-2022)
  • 6.1.2 APAC Nicotinamide Mononucleotide Supplement Revenue by Region (2017-2022)
• 6.2 APAC Nicotinamide Mononucleotide Supplement Sales by Type
• 6.3 APAC Nicotinamide Mononucleotide Supplement Sales by Sales Channel
• 6.4 China
• 6.5 Japan
• 6.6 South Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 China Taiwan

7 Europe

• 7.1 Europe Nicotinamide Mononucleotide Supplement by Country
  • 7.1.1 Europe Nicotinamide Mononucleotide Supplement Sales by Country (2017-2022)
  • 7.1.2 Europe Nicotinamide Mononucleotide Supplement Revenue by Country (2017-2022)
• 7.2 Europe Nicotinamide Mononucleotide Supplement Sales by Type
• 7.3 Europe Nicotinamide Mononucleotide Supplement Sales by Sales Channel
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia

8 Middle East & Africa

• 8.1 Middle East & Africa Nicotinamide Mononucleotide Supplement by Country
  • 8.1.1 Middle East & Africa Nicotinamide Mononucleotide Supplement Sales by Country (2017-2022)
  • 8.1.2 Middle East & Africa Nicotinamide Mononucleotide Supplement Revenue by Country (2017-2022)
• 8.2 Middle East & Africa Nicotinamide Mononucleotide Supplement Sales by Type
• 8.3 Middle East & Africa Nicotinamide Mononucleotide Supplement Sales by Sales Channel
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers & Growth Opportunities
• 9.2 Market Challenges & Risks
• 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

• 10.1 Raw Material and Suppliers
• 10.2 Manufacturing Cost Structure Analysis of Nicotinamide Mononucleotide Supplement
• 10.3 Manufacturing Process Analysis of Nicotinamide Mononucleotide Supplement
• 10.4 Industry Chain Structure of Nicotinamide Mononucleotide Supplement

11 Marketing, Distributors and Customer

• 11.1 Sales Channel
  • 11.1.1 Direct Channels
  • 11.1.2 Indirect Channels
• 11.2 Nicotinamide Mononucleotide Supplement Distributors
• 11.3 Nicotinamide Mononucleotide Supplement Customer

12 World Forecast Review for Nicotinamide Mononucleotide Supplement by Geographic Region

• 12.1 Global Nicotinamide Mononucleotide Supplement Market Size Forecast by Region
  • 12.1.1 Global Nicotinamide Mononucleotide Supplement Forecast by Region (2023-2028)
  • 12.1.2 Global Nicotinamide Mononucleotide Supplement Annual Revenue Forecast by Region (2023-2028)
• 12.2 Americas Forecast by Country
• 12.3 APAC Forecast by Region
• 12.4 Europe Forecast by Country
• 12.5 Middle East & Africa Forecast by Country
• 12.6 Global Nicotinamide Mononucleotide Supplement Forecast by Type
• 12.7 Global Nicotinamide Mononucleotide Supplement Forecast by Sales Channel

13 Key Players Analysis

• 13.1 Double Wood Supplements
  • 13.1.1 Double Wood Supplements Company Information
  • 13.1.2 Double Wood Supplements Nicotinamide Mononucleotide Supplement Product Offered
  • 13.1.3 Double Wood Supplements Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.1.4 Double Wood Supplements Main Business Overview
  • 13.1.5 Double Wood Supplements Latest Developments
• 13.2 Quicksilver Scientific
  • 13.2.1 Quicksilver Scientific Company Information
  • 13.2.2 Quicksilver Scientific Nicotinamide Mononucleotide Supplement Product Offered
  • 13.2.3 Quicksilver Scientific Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.2.4 Quicksilver Scientific Main Business Overview
  • 13.2.5 Quicksilver Scientific Latest Developments
• 13.3 California Gold Nutrition
  • 13.3.1 California Gold Nutrition Company Information
  • 13.3.2 California Gold Nutrition Nicotinamide Mononucleotide Supplement Product Offered
  • 13.3.3 California Gold Nutrition Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.3.4 California Gold Nutrition Main Business Overview
  • 13.3.5 California Gold Nutrition Latest Developments
• 13.4 ProHealth Longevity
  • 13.4.1 ProHealth Longevity Company Information
  • 13.4.2 ProHealth Longevity Nicotinamide Mononucleotide Supplement Product Offered
  • 13.4.3 ProHealth Longevity Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.4.4 ProHealth Longevity Main Business Overview
  • 13.4.5 ProHealth Longevity Latest Developments
• 13.5 Renue by Science
  • 13.5.1 Renue by Science Company Information
  • 13.5.2 Renue by Science Nicotinamide Mononucleotide Supplement Product Offered
  • 13.5.3 Renue by Science Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.5.4 Renue by Science Main Business Overview
  • 13.5.5 Renue by Science Latest Developments
• 13.6 Do Not Age
  • 13.6.1 Do Not Age Company Information
  • 13.6.2 Do Not Age Nicotinamide Mononucleotide Supplement Product Offered
  • 13.6.3 Do Not Age Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.6.4 Do Not Age Main Business Overview
  • 13.6.5 Do Not Age Latest Developments
• 13.7 Nutriop
  • 13.7.1 Nutriop Company Information
  • 13.7.2 Nutriop Nicotinamide Mononucleotide Supplement Product Offered
  • 13.7.3 Nutriop Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.7.4 Nutriop Main Business Overview
  • 13.7.5 Nutriop Latest Developments
• 13.8 AFEGA Anti-Aging-Shop
  • 13.8.1 AFEGA Anti-Aging-Shop Company Information
  • 13.8.2 AFEGA Anti-Aging-Shop Nicotinamide Mononucleotide Supplement Product Offered
  • 13.8.3 AFEGA Anti-Aging-Shop Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.8.4 AFEGA Anti-Aging-Shop Main Business Overview
  • 13.8.5 AFEGA Anti-Aging-Shop Latest Developments
• 13.9 Borealis
  • 13.9.1 Borealis Company Information
  • 13.9.2 Borealis Nicotinamide Mononucleotide Supplement Product Offered
  • 13.9.3 Borealis Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.9.4 Borealis Main Business Overview
  • 13.9.5 Borealis Latest Developments
• 13.10 MAAC10 Formulas
  • 13.10.1 MAAC10 Formulas Company Information
  • 13.10.2 MAAC10 Formulas Nicotinamide Mononucleotide Supplement Product Offered
  • 13.10.3 MAAC10 Formulas Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.10.4 MAAC10 Formulas Main Business Overview
  • 13.10.5 MAAC10 Formulas Latest Developments
• 13.11 Xi'an Angel Biotechnology Co., Ltd.
  • 13.11.1 Xi'an Angel Biotechnology Co., Ltd. Company Information
  • 13.11.2 Xi'an Angel Biotechnology Co., Ltd. Nicotinamide Mononucleotide Supplement Product Offered
  • 13.11.3 Xi'an Angel Biotechnology Co., Ltd. Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.11.4 Xi'an Angel Biotechnology Co., Ltd. Main Business Overview
  • 13.11.5 Xi'an Angel Biotechnology Co., Ltd. Latest Developments
• 13.12 Longevity Box
  • 13.12.1 Longevity Box Company Information
  • 13.12.2 Longevity Box Nicotinamide Mononucleotide Supplement Product Offered
  • 13.12.3 Longevity Box Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.12.4 Longevity Box Main Business Overview
  • 13.12.5 Longevity Box Latest Developments
• 13.13 Age Science
  • 13.13.1 Age Science Company Information
  • 13.13.2 Age Science Nicotinamide Mononucleotide Supplement Product Offered
  • 13.13.3 Age Science Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.13.4 Age Science Main Business Overview
  • 13.13.5 Age Science Latest Developments
• 13.14 Nutravita
  • 13.14.1 Nutravita Company Information
  • 13.14.2 Nutravita Nicotinamide Mononucleotide Supplement Product Offered
  • 13.14.3 Nutravita Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.14.4 Nutravita Main Business Overview
  • 13.14.5 Nutravita Latest Developments
• 13.15 Hebei Paihang Import And Export Co., Ltd.
  • 13.15.1 Hebei Paihang Import And Export Co., Ltd. Company Information
  • 13.15.2 Hebei Paihang Import And Export Co., Ltd. Nicotinamide Mononucleotide Supplement Product Offered
  • 13.15.3 Hebei Paihang Import And Export Co., Ltd. Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.15.4 Hebei Paihang Import And Export Co., Ltd. Main Business Overview
  • 13.15.5 Hebei Paihang Import And Export Co., Ltd. Latest Developments
• 13.16 Aeternum
  • 13.16.1 Aeternum Company Information
  • 13.16.2 Aeternum Nicotinamide Mononucleotide Supplement Product Offered
  • 13.16.3 Aeternum Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.16.4 Aeternum Main Business Overview
  • 13.16.5 Aeternum Latest Developments
• 13.17 Toniiq
  • 13.17.1 Toniiq Company Information
  • 13.17.2 Toniiq Nicotinamide Mononucleotide Supplement Product Offered
  • 13.17.3 Toniiq Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.17.4 Toniiq Main Business Overview
  • 13.17.5 Toniiq Latest Developments
• 13.18 ProNutrition
  • 13.18.1 ProNutrition Company Information
  • 13.18.2 ProNutrition Nicotinamide Mononucleotide Supplement Product Offered
  • 13.18.3 ProNutrition Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.18.4 ProNutrition Main Business Overview
  • 13.18.5 ProNutrition Latest Developments
• 13.19 Genex Formulas
  • 13.19.1 Genex Formulas Company Information
  • 13.19.2 Genex Formulas Nicotinamide Mononucleotide Supplement Product Offered
  • 13.19.3 Genex Formulas Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.19.4 Genex Formulas Main Business Overview
  • 13.19.5 Genex Formulas Latest Developments
• 13.20 Physicians Longevity
  • 13.20.1 Physicians Longevity Company Information
  • 13.20.2 Physicians Longevity Nicotinamide Mononucleotide Supplement Product Offered
  • 13.20.3 Physicians Longevity Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.20.4 Physicians Longevity Main Business Overview
  • 13.20.5 Physicians Longevity Latest Developments
• 13.21 AlphaFit
  • 13.21.1 AlphaFit Company Information
  • 13.21.2 AlphaFit Nicotinamide Mononucleotide Supplement Product Offered
  • 13.21.3 AlphaFit Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.21.4 AlphaFit Main Business Overview
  • 13.21.5 AlphaFit Latest Developments
• 13.22 Mega NMN
  • 13.22.1 Mega NMN Company Information
  • 13.22.2 Mega NMN Nicotinamide Mononucleotide Supplement Product Offered
  • 13.22.3 Mega NMN Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.22.4 Mega NMN Main Business Overview
  • 13.22.5 Mega NMN Latest Developments
• 13.23 Lovita Foods
  • 13.23.1 Lovita Foods Company Information
  • 13.23.2 Lovita Foods Nicotinamide Mononucleotide Supplement Product Offered
  • 13.23.3 Lovita Foods Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.23.4 Lovita Foods Main Business Overview
  • 13.23.5 Lovita Foods Latest Developments
• 13.24 Jarrow Formulas
  • 13.24.1 Jarrow Formulas Company Information
  • 13.24.2 Jarrow Formulas Nicotinamide Mononucleotide Supplement Product Offered
  • 13.24.3 Jarrow Formulas Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.24.4 Jarrow Formulas Main Business Overview
  • 13.24.5 Jarrow Formulas Latest Developments
• 13.25 Body Union
  • 13.25.1 Body Union Company Information
  • 13.25.2 Body Union Nicotinamide Mononucleotide Supplement Product Offered
  • 13.25.3 Body Union Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.25.4 Body Union Main Business Overview
  • 13.25.5 Body Union Latest Developments
• 13.26 Peak Performance
  • 13.26.1 Peak Performance Company Information
  • 13.26.2 Peak Performance Nicotinamide Mononucleotide Supplement Product Offered
  • 13.26.3 Peak Performance Nicotinamide Mononucleotide Supplement Sales, Revenue, Price and Gross Margin (2020-2022)
  • 13.26.4 Peak Performance Main Business Overview
  • 13.26.5 Peak Performance Latest Developments

14 Research Findings and Conclusion